20251110_KAEF_Pengumuman RUPS_31984109_lamp1.pdf

                               ANNOUNCEMENT
             EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF 2025
                              PT KIMIA FARMA Tbk

The Shareholders of PT Kimia Farma Tbk (the “Company”) are hereby notified that the
Company will convene the Extraordinary General Meeting of Shareholders of 2025 (the
“MEETING”) electronically (e-GMS) on Wednesday, December 17, 2025.
Shareholders who are entitled to attend the MEETING are those whose names are recorded
in the Company’s Shareholders Register and/or the owners of the Company’s shares recorded
in the securities sub-accounts of PT Kustodian Sentral Efek Indonesia (KSEI) at the closing of
trading of the Company’s shares on the Indonesia Stock Exchange (IDX) on Monday,
November 24, 2025.
Shareholders who are entitled to attend the MEETING shall be provided with the opportunity
to grant their attendance and voting rights electronically by using the e-Proxy facility through
the eASY.KSEI system, which can be accessed via https://easy.ksei.co.id.
Pursuant to the provisions of the Company’s Articles of Association and Financial Services
Authority Regulation (POJK) No. 15/POJK.04/2020, the Notice of the Meeting will be
announced on the website of the Indonesia Stock Exchange (www.idx.co.id), eASY.KSEI
(https://easy.ksei.co.id), and the Company’s website (www.kimiafarma.co.id) on Tuesday,
November 25, 2025.
Referring to the provisions of Article 16 of OJK Regulation No. 15/POJK.04/2020, one or more
shareholders representing 1/20 (one-twentieth) or more of the total number of shares with
valid voting rights may propose an agenda item for the MEETING in writing to the Board of
Directors no later than 7 (seven) days prior to the Notice of the Meeting, namely on Tuesday,
November 18, 2025, by including the reasons and supporting materials for the proposed
agenda item, provided that such proposal complies with the prevailing laws and regulations.



                                 Jakarta, November 10, 2025
                                     PT Kimia Farma Tbk
                                      Board of Directors